This symposium aims to highlight the recent advances and applications of label-free high-throughput cell-based and affinity-selection mass spectrometry (MS) screening assay technologies as an emerging lead discovery strategy. The symposium will bring together leading academic and industry experts to reflect on the opportunities and challenges to exploit state-of-the-art MS-based screening methods to accelerate the discovery of novel starting points for drug discovery.
Venue:
Panoramazaal at Pivot Park
Location: Netherlands
Country: United Kingdom
Organiser Contact Details:
ELRIG UKT:
0044 1904 405177info@elrig.org
